Skip to main content

Table 1 Participants’ demographic data as characteristics associated with time-to-dropout, with early death as a competing risk

From: Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: an exploratory study

 

n

Time-to-dropout with death as a competing risk

Death

SHR

(95%CI)

HR

(95%CI)

Study group

 Intervention

150

1.23

(0.76, 1.99)

1.26

(0.84, 1.88)

 Control

212

1

 

1

 

Age (years)

362

1.01

(0.99, 1.03)

1.02

(1.00, 1.03)

Study site

 Study site 1

119

1

   

 Study site 2

98

1.77

(0.94, 3.33)

1.69

(0.99, 2.89)

 Study site 3

145

1.60

(0.87, 2.93)

1.99

(1.22, 3.26)

Sex

 Male

219

1.35

(0.82, 2.24)

0.75

(0.51, 1.11)

 Female

143

1

 

1

 

Family status

 Married

226

1.15

(0.50, 2.67)

1.68

(0.84, 3.38)

 Single

44

1

 

1

 

 Divorced/Widowed

63

2.71

(1.12, 6.56)

0.89

(0.36, 2.20)

Time since diagnosis

  ≤ 6 months

187

1

 

1

 

 7–12 months

49

0.43

(0.17, 1.08)

1.06

(0.58, 1.93)

 13–24 months

46

0.54

(0.22, 1.32)

1.53

(0.87, 2.67)

  > 24 months

80

0.97

(0.54, 1.72)

1.33

(0.81, 2.19)

Diagnosis

 Acute leukemia

69

1

 

1

 

 Aggressive lymphoma

58

1.53

(0.64, 3.65)

0.55

(0.25, 1.23)

 Malignant neoplasm of the bronchus and lungs

62

1.92

(0.84, 4.38)

1.78

(0.97, 3.27)

 Metastatic colorectal cancer/colon carcinoma

78

1.39

(0.60, 3.21)

1.19

(0.64, 2.21)

 Malignant neoplasm of the pancreas

32

1.94

(0.79, 4.77)

2.48

(1.27, 4.85)

 Multiple myeloma and malignant plasma cell neoplasms

24

1.24

(0.40, 3.83)

0.56

(0.19, 1.65)

 Metastasized malignant neoplasm of the breast

9

0.91

(0.11, 7.21)

0.41

(0.05, 3.10)

 Others

30

2.13

(0.79, 5.74)

1.32

(0.58, 3.03)

Education

 Low

29

1.85

(0.90, 3.81)

0.92

(0.39, 2.15)

 Medium

101

1.27

(0.72, 2.25)

1.58

(1.02, 2.45)

 High

206

1

 

1

 

Social support (OSSS-3)

 Poor (3–8)

35

2.10

(1.01, 4.35)

0.83

(0.39, 1.79)

 Moderate (9–11)

158

1.32

(0.74, 2.36)

0.87

(0.56, 1.36)

 Strong (12–14)

139

1

 

1

 
  1. n Number of observation, SHR Sub-hazard ratio, HR Hazard ratio, CI Confidence Interval